Prior to the molecular era, most IDH2-mutant, NUT midline, and SWI/SNF-deficient SNCs were categorized as SNUC, PDCA, TCS, or NEC (2, 3, 5, 33). Here, IDH2 is linked to neuroendocrine carcinoma.